# Rubedo Life Sciences: Biotechnology, Sunnyvale, United States

> Rubedo Life Sciences: Rubedo Life Sciences is a clinical-stage biopharmaceutical company based in Sunnyvale, California, with a European presence in Milan...

Source: https://millionrounds.com/startup/rubedo-life-sciences (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Rubedo Life Sciences

Rubedo Life Sciences is a clinical-stage biopharmaceutical company based in Sunnyvale, California, with a European presence in Milan, Italy.

Funding reported Last round: Series A

Biotechnology Sunnyvale, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 32 11 to 50 people
- **Funding reported:** $53M in dollars
- **Last round:** Series A Apr 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Rubedo Life Sciences has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Rubedo Life Sciences

Rubedo Life Sciences is a clinical-stage biopharmaceutical company based in Sunnyvale, California, with a European presence in Milan, Italy.

Founded in 2018, the company focuses on discovering and developing innovative therapeutics that target senescent cells and other contributors to aging and chronic diseases. Its mission is to extend human healthspan and lifespan by eliminating the cellular drivers of age-related pathologies. The company utilizes its proprietary ALEMBICTM drug discovery platform, which employs AI and machine learning to identify druggable targets associated with senescent cells. Rubedo is developing selective cellular rejuvenation medicines, including its lead candidate RLS-1496, a GPX4 modulator aimed at treating conditions such as plaque psoriasis and idiopathic pulmonary fibrosis. Rubedo is actively engaged in clinical trials to validate the safety and efficacy of its therapies, with plans for further development in neurodegenerative and metabolic disorders.

## What company datasets say Rubedo Life Sciences raised

Funding, as reported

Reported in all **$53M** in dollars

Rounds **5**

Last round **Series A**

Last round size **$40M**

Last round date **Apr 2024**

Investors listed **13**

## Founders and team

From Rubedo Life Sciences's own website: 2 on the team.

- **Alex Laslavic** Chief Technology Officer
- **Machine Learning** Associate Professor of Molecular

Advisers *John Harris*

## On 9 portfolio pages

Investors who name them

- [The Longevity Fund](https://millionrounds.com/fund/the-longevity-fund)
- [Beiersdorf](https://millionrounds.com/fund/beiersdorf)
- [Modi Ventures](https://millionrounds.com/fund/modi-ventures)
- [B-Engine](https://millionrounds.com/fund/b-engine)
- [Moonstone VC](https://millionrounds.com/fund/moonstone-venture-capital)
- [LongeVC](https://millionrounds.com/fund/longevc)
- [Evolution VC](https://millionrounds.com/fund/evolution-vc)
- [IKJ Capital](https://millionrounds.com/fund/ikj-capital)
- [CDP Venture Capital](https://millionrounds.com/fund/cdp-venture-capital)

Each firm lists Rubedo Life Sciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care senescence targeting cellular rejuvenation translational research biological youth disease modification cell therapy longevity medicine cell targeting single-cell omics biogerontology chemoinformatics hospital & health care biomedical innovation medical target validation

Built with from their website

Google Workspace Google Meet Mist React Alembico EMR Visio Wix Microsoft 365 Gmail

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, 32541, SIC 2834, 8731
- **Region:** California
- **Revenue:** $4.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/rubedo-life-sciences)

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put Rubedo Life Sciences in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)